The Canadian ADHD Practice Guidelines 4.1. Edition (January 2020) provides comprehensive, evidence-based guidance on the screening, assessment and treatment of ADHD for healthcare professionals. Developed by a multidisciplinary team of ADHD experts—including pediatricians, psychiatrists, psychologists, family physicians, and educators—these guidelines ensure best practices in ADHD care. Available in multiple formats.
The Canadian ADHD Practice Guidelines are:
- Based on the latest peer-reviewed research;
- Rooted in expert consensus where evidence is limited;
- Independently funded by CADDRA, ensuring unbiased recommendations;
- Reviewed by Canadian and International specialists.
The latest 4.1 edition of the Guidelines (January 2020) is available digitally or as a PDF. The Guidelines have been in constant review for almost twenty years. The fourth edition of the Canadian ADHD Practice Guidelines evolved from earlier editions published in 2006, 2008, and 2011. A multidisciplinary team that included ADHD specialists, pediatricians, psychiatrists, psychologists, family physicians, pharmacists, nurses, educators and community stakeholders from across Canada and from the US contributed to its writing and review.
Conflicts of interest were recorded for all individuals that were a part of the process and are included in the Guidelines. As has been the case since the 1st edition of the Canadian ADHD Guidelines, all authors have donated their time and shared their expertise without receiving any financial contribution. The final draft of the 4th edition was independently reviewed by a range of relevant stakeholders (e.g., adult psychiatrist, child and adolescent psychiatrist, psychologist, patient advocate/nurse, family physician). The Guidelines development process was fully funded by CADDRA and occurred without external financial grants.